Fitness to Practise Cases
This archive contains General Pharmaceutical Council (GPhC) Fitness to Practise (FtP) case summaries, detailing regulatory decisions affecting pharmacy professionals in the UK.
Each case provides insight into professional misconduct, errors, and ethical breaches that led to sanctions such as suspension, removal, or warnings. These summaries are valuable for:
- Pharmacists & Pharmacy Technicians – to understand common regulatory pitfalls.
- Employers & HR Teams – to learn about professional accountability and compliance.
- Pharmacy Students – to prepare for real-world ethical challenges in pharmacy practice.
Why it matters:
The decisions in these cases shape the legal and ethical landscape of pharmacy practice. Staying informed can help pharmacy professionals avoid similar mistakes and maintain high professional standards.
Use the form below to search for and filter cases that match your interests
Page 5 of 54
Pharmacist Suspension Extended After POM Theft from Workplace as GPhC Finds Ongoing Risk of Repetition
Allegations This case concerned a pharmacist who repeatedly removed prescription-only medicines from their workplace for personal use or benefit without making payment and while knowing that they were not entitled to take them. The medicines involved were clinically significant and included medication containing codeine, omeprazole and Naramig 2.5 mg tablets. The codeine-containing medication was removed […]
5 August 2026
GPhC Finds No Impairment After Pharmacist’s Cocaine and Cannabis Misuse: Lessons on Abstinence, Insight and Remediation
Allegations This case concerned a pharmacist’s use of cocaine and cannabis outside the workplace and the subsequent assessment of whether the pharmacist remained fit to practise after serving a period of suspension. The first allegation related to the registrant’s consumption of cocaine between mid-March and mid-June 2017. Cocaine is legally classified as a Class A […]
1 August 2026
GPhC Warning After Pharmacist Failed to Verify Patient Identity Before Supervised Buprenorphine Supply
Allegations This case arose from the supply and supervised consumption of buprenorphine 12 mg tablets under a controlled drug prescription. Buprenorphine was identified in the determination as a Schedule 3 controlled drug. The registrant was responsible not only for dispensing the medicine but also for supervising its consumption. Before carrying out these activities, the registrant […]
31 July 2026
12-Month Warning For Pharmacist Who Accessed Medical Records of Colleague and Partner Without Clinical Justification
Allegations This case concerned repeated unauthorised access to electronic patient records by a hospital pharmacist. At the relevant time, the registrant was working as a rotational pharmacist in an Aseptic Preparation Unit responsible for preparing and dispensing medicines for oncology patients. The first incident arose on 18 May 2020 after a member of the pharmacy […]
30 July 2026
Boots Pharmacist Tutor Suspended Over Sexualised WhatsApp Messages and Boundary Breach with Trainee
Allegations This case concerned serious sexual misconduct towards a junior member of a pharmacy team. The registrant was an experienced pharmacist who had been given responsibility for tutoring a trainee pharmacy adviser. Before the relevant events, communications between the two had largely been work-related and the trainee regarded the registrant as a good tutor. The […]
24 July 2026
Pharmacist Suspended After Homophobic 999-Call Misuse, Police Assault and Threatening Behaviour Convictions
Allegations This case concerned three criminal convictions arising from two separate incidents in 2021. Although the events occurred outside the pharmacy workplace and did not involve medicines, dispensing, prescribing or direct patient care, the Fitness to Practise Committee considered that they raised serious questions about the registrant’s behaviour, emotional regulation and ability to maintain the […]
22 July 2026
GPhC Warning Issued Over Unsafe Mounjaro Prescribing at an Unregulated Aesthetic Clinic
Allegations This case concerned the prescribing of Mounjaro, described in the determination as a high-risk injectable weight-loss medication, by a pharmacist independent prescriber working at an unregulated aesthetic clinic during a short period between 28 April 2025 and 12 May 2025. The central concern was not simply that prescribing took place remotely. Rather, the Committee […]
21 July 2026
Superintendent Pharmacist Warned Over Indemnity Insurance Failings and Incomplete Responsible Pharmacist Logs
Allegations This case concerned the governance responsibilities of a superintendent pharmacist and, in particular, the obligation to ensure that fundamental legal, professional and operational safeguards were maintained within a pharmacy business. The registrant held the position of superintendent pharmacist between 1 November 2022 and 28 February 2025. The GPhC described this as a strategic role […]
10 July 2026
GPhC Warning for Pharmacist Who Supplied POMs Without Valid Prescriptions or Emergency Supply Procedures
Allegations This case concerned a registered pharmacist who was working as the regular Responsible Pharmacist at a community pharmacy in Plymouth. The relevant events occurred over approximately three months, between February and April 2023. The concerns were raised by a Primary Care Network Hub and related to the supply of medicines to two patients who […]
Pharmacist Suspended After Attending Work Unfit and Dumping Controlled Drugs in Public Park
Allegations This case concerned a pharmacist working as the Responsible Pharmacist at a community pharmacy in Heswall, Wirral. The allegations fell into three broad areas: record keeping around Responsible Pharmacist and controlled drug records, attending work while unfit, and unsafe disposal of medicines and confidential pharmacy waste. The first allegation related to the period between […]
8 July 2026